Sponsor
Dana-Farber Cancer Institute
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT03367247
This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.
Intervention
Enhanced Discharge Planning (EDP), BOLSTER
Condition
Gynecologic Cancer, Gastrointestinal Cancer
Investigators
Alexi A Wright, MD, MPH